Progyny(US:PGNY)2022-05-06 20:21Financial Position - The company reported cash and cash equivalents of $38.8 million and marketable securities of $66.9 million as of March 31, 2022[175]. - A hypothetical 10% change in interest rates would not result in a material impact on the company's consolidated financial statements[176]. - The company does not believe that inflation has had a material effect on its business, financial condition, or results of operations[177]. Business Operations - The ongoing COVID-19 pandemic continues to have an adverse impact on the company's business and operations[16]. - The company has a history of operating losses and may not sustain profitability in the future[16]. - The company relies on retaining existing clients and increasing service adoption to maintain its financial health[16]. - A significant portion of the company's revenue comes from its largest clients, primarily in the technology industry[16]. - The company operates in a highly regulated industry and must comply with complex legal and regulatory requirements[22]. Internal Controls - The effectiveness of the company's disclosure controls and procedures was evaluated and deemed effective at the reasonable assurance level as of March 31, 2022[179]. - There were no changes in the company's internal control over financial reporting that materially affected its financial reporting during the quarter ended March 31, 2022[180].